The FDA’s decision will threaten the ability of compounding pharmacies to make far cheaper, unbranded versions of the ...

Researchers said the study backs up anecdotal evidence from patients and doctors that semaglutide can lead to a sudden loss ...

Shares tumbled 21% to $52.22. Over the last year, the stock has surged more than 450%.

The FDA has declared an end to the shortage of Novo Nordisk’s blockbuster drug semaglutide, threatening the ability for ...

Entering Prime IV Hydration & Wellness in Orem is like entering a spa, rather than a physician’s office, with the lights ...

Many of these unlawful and unauthorized shipments were explicitly tagged for compounding, which in turn could put many ...

A recent review and meta-analysis of semaglutide studies found that this drug can significantly reduce the risk of ...

Two Omaha women lost more than 300 lbs. combined with injections of a GLP-1 drug, which are used increasingly for weight loss ...

A randomized, placebo-controlled trial validates a side effect frequently observed by doctors and patients. A new study from ...

More than three dozen attorneys general are urging the FDA to take “decisive action” against counterfeit obesity drugs.

New research suggests semaglutide, marketed as Ozempic for diabetes and Wegovy for obesity, could help people reduce their alcohol consumption.

Adults with type 2 diabetes may have a higher risk for developing nonarteritic anterior ischemic optic neuropathy while using ...